London, Großbritannien
CHF 1 - CHF 540,050
I built two #1 franchises that dominated UK life sciences investment banking for over ten years. I helped advise, finance, and build some of the most successful public and private companies in the sector, with several £1bn+ successes, including Oxford Nanopore, Abcam, Syncona, Oxford Sciences, Exscientia, Clinigen, Vectura, PureTech, The Binding Site and IP Group. I have worked with many other life sciences companies also, and with many talented entrepreneurs, executives, investors and advisors during my time in the city.
As a top-ranked life sciences analyst from the early 2000s through to 2022, I have a strong track record of identifying companies with promising technologies or business models at a relatively early stage and working with them across their lifecycle.
Medizin und Pharma
Finanzen
Technologie
AIN hilft Investoren und Unternehmern, dauerhafte und profitable Beziehungen aufzubauen, um bessere Geschäfte und eine bessere Zukunft zu schaffen.